Covidien (NYSE:COV) has topped Wall Street expectations for the last five quarters, and it will try to keep that streak alive as it reports the latest earnings on Thursday.
Continue Reading Below
Analysts currently expect Covidien to come in with earnings of $1.06 per share on revenues of $3.01 billion. Analysts gave estimates ranging from earnings per share to earnings per share. The average estimate has shown no movement over the last three months.
In terms of price changes, the stock's best recent streak was when it gained $2.85 per share between June 1, 2012 and June 20, 2012. Looking at change over the last three months, April 25, 2012 and July 20, 2012, the stock price fell $1.44 (-2.6%), from $54.74 to $53.30.
Company Fundamental Trends
Analysts are bullish on the stock as 15 analysts rate it as a buy and only one analyst rate it as a sell. Analyst sentiment has been improving recently, as the average rating risen slightly over the past three months.
Last Quarter's Results
In the second quarter, profit rose 9.2% to $497 million ($1.02 a share) from $455 million (91 cents a share) the year earlier, exceeding analyst expectations. Revenue rose 5.2% to $2.95 billion from $2.8 billion.
Reporting Period: 3Q
Date of Release: Thursday, July 26, 2012 before market open
Revenue Estimate: $3.01 billion
(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)